-
Flonase continues market strength
GSK Consumer Healthcare’s Flonase allergy remedy was the single greatest generator of incremental dollars for the 52 weeks ended May 15 across total U.S. multi-outlets, according to IRI data, with $345.2 million in sales on 209.9% growth. The question headed into its second year on OTC shelves is can it maintain its momentum now that private-label competition for Flonase has reached store shelves.
-
Treatments among hottest lip products
Lip color is the sexy part of the category — especially the onslaught of dark hues and glossy finishes dominating the market. But the real growth right now is in treatments. Whether it’s the drying effect of the new matte finishes or just abuse from the weather, lips are in need of moisturizing.